Standad and Novel Biomarkers for Ovarian Cancer 최문선 ∙ 정희윤 1.

Slides:



Advertisements
Similar presentations
Dr. Amal S. Ahmed Ass Prof.Clinical Pathology Suez Canal University
Advertisements

Audit of Impact of NICE guidelines for Ovarian Cancer Helen Losty Royal United Hospital Bath 17th November 2011.
Ovarian Cancer Gloria S. Huang, M.D. Assistant Professor Department of Obstetrics & Gynecology and Women ’ s Health Division of Gynecologic Oncology Albert.
A significant increase in the incidence of endometrial cancer. This increased incidence of endometrial cancer has been widely interpreted to be a result.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Breast Cancer By Kajal Haghmoradi.
OVARIAN CANCER Talking point: Genetics of ovarian cancer.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture By: Reem Sallam, MD, MSc, PhD.
Positron Emission Tomography (PET) Scans in Ovarian Cancer Effectiveness of PET Scans and Recommendations for CMS August 20, 2008 Ovarian Cancer National.
Focus on Ovarian Cancer (Relates to Chapter 54, “Nursing Management: Female Reproductive Problems,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc.,
FRONTIERS IN TUMOR MARKERS Robert C. Bast, Jr., M.D. U.T. M.D. Anderson Cancer Center October 16, 2006.
White blood cells & the immune system What does it mean to be immune to something? Leucocyte (WBC) Phagocytes (engulf & destroy) = Inflammation Lymphocytes.
Eleni Galani Medical Oncologist
Tumor Markers: Clinical Usefulness
Neoplasms.
بسم الله الرحمن الرحيم.
BMED Project 1 Group: Eric Sood Hamza Darb Jean Wall Matt Richner Regina Chang Mickael Gueye OVARIAN CANCER SCREENING PROBLEM
Atoosa Adibi MD. Department of Radiology Isfahan University Of Medical Sciences.
Management of ovarian cysts
Tumor Markers Lecture two By Dr. Reem Sallam. Objectives  To briefly enumerate the most commonly used methods to test for tumor markers  To describe.
Role of Biomarkers in Management of Prostate Cancer Dr. Angela Amayo Specialist Pathologist 13 th April 2012.
OF COLOREATAL CANCER USING SEROLOGIC TUMOR MARKERS DIAGNOSIS & MANAGEMENT.
OVARIAN CANCER RISK FACTORS Studies have found the following risk factors for ovarian cancer:  Family history of cancer: Women who have a mother, daughter,
Tumor markers Present; by Dr. Andalib Isfahan Medical School
Clinical Division of Oncology Department of Medicine I Medical University of Vienna, Austria Tumormarkers.
وما أوتيتم من العلم إلا قليلاً. Prepared by: Abdo A Elfiky.
Tumor Markers.
CA-125 Cancer Antigen-125 Discovered in l981
Animal Form & Function Immune System AP Biology. Nonspecific Defenses  Do not discriminate  Present at birth  Prevent approach of pathogens.
吳 華 席 Hua-Hsi Wu, MD OB/GYN, VGH-TPE Aug 12, 2008
Male Reproductive System Kristine Krafts, M.D.. Male Reproductive System Outline Testis Prostate.
CANCER CONTROL NHPA’s. What is it? Cancer is a term to describe a diverse group of diseases in which some of the cells in body become defective. The following.
Arrays for Point-of-Care Early Cancer Detection James F. Rusling Departments of Chemistry & Cell Biology University of Connecticut and UCHC Storrs, CT,
SUSAN G. KOMEN CENTRAL GEORGIA AFFILIATE WE LIVE HERE. WE RACE HERE. WE SAVE LIVES HERE.
Gynecological Malignancies. Gynecologic malignancies account for 15% of all cancers in women. Gynecologic malignancies account for 15% of all cancers.
Tumor Markers American cancer society British Journal of Cancer By B.Heidari.
Dr. Ranjit Kumar Scientist - I Mahavir Cancer Sansthan Patna, India.
Biochemical markers for diagnosis of diseases and follow up Dr. Rana Hasanato Associate professor and consultant Head of clinical chemistry department.
Better Health. No Hassles. Ovarian Cancer Sokan Hunro, PAC, MPH.
Breast Cancer 1. Leukemia & Lymphoma New diagnoses each year in the US: 112, 610 Adults 5,720 Children 43,340 died of leukemia or lymphoma in
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Unit 6: Tumor markers. Introduction… Cancer is the second leading cause of death in North America, accounting for > 2.7 million deaths annually Although.
Cancer Antigen 15-3 Alison Nolan DT204/2. What is Cancer?  Cancer is a disease which is characterized by uncontrolled proliferation of cells.  This.
Cell Biology & Cancer Unit Objective 1 Cancer types, incidence, pre-disposition, and risk factors Biomedical Technology.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
INTRODUCTION & OBJECTIVES Introduction: The carcinogenesis of hepatocellular carcinoma (HCC) is a multifactorial, multistep and complex process. Its prognosis.
Odor-based Sensors for Ovarian Cancer Detection
Lecture Fifteen Biomedical Engineering for Global Health.
Golgi Protein-73 Shows Promise as a Sensitive Serum Marker for HCC Slideset on: Marrero J, Romano P, Nikolaeva O, et al. GP73, a resident golgi glycoprotein,
HOW TO STOP CANCER How To Stop Cancer a book written by professor J. Dean which provides you an informative alternative cancer treatment that will assist.
Common pitfall in Oncology Luangyot Thongthieang, MD MEDICAL ONCOLOGY UNIT INTERNAL MEDICINE, KHONKAEN HOSPITAL.
Date of download: 9/18/2016 Copyright © 2016 SPIE. All rights reserved. Quantitative analysis of immunoblots using light-sensitive film. (a) A densitometry.
Tumor markers 1111.
Podocalyxin-Like Protein 1 Expression and Correlation with Clinical Characteristics in Epithelial Serous and Mucinous Ovarian Carcinoma and Tumor-Like.
Male Reproductive System
Breast Cancer: The number speaks
Screening for Ovarian Cancer
Survivors Teaching Students: Saving Women’s LivesSM
Biomarkers of ovarian cancer and cysts
Performance Comparison of CA125 and the Combination of the Other Serum Biomarkers for the Early Detection of the Ovarian Cancer Hye-Jeong Song1,3,
Biomarkers of ovarian cancer and cysts
objectives Methods Results conclusion
What is the role of genetic testing in patients with ovarian cancer?
BT08.01 Cell Biology and Cancer
Ovarian Cancer-Route to Diagnosis
What Does BRCA Have to Do With It? PARP Inhibitors in Ovarian Cancer
Biochemical markers for diagnosis of diseases and follow up
Sensitivity and specificity plots of human epididymis protein 4 (HE4) (A and B, respectively) and carbohydrate antigen 125 (CA-125) (C and D, respectively)
Lan-Huong Tran, PhD Student - Hasselt University
The Company VOC Diagnostics AB
Presentation transcript:

Standad and Novel Biomarkers for Ovarian Cancer 최문선 ∙ 정희윤 1

I.Ovarian Cancer II.Biomarkers 2

I.Ovarian Cancer ◆ Female reproductive organs 3

I.Ovarian Cancer 4 − EPITHELIAL OVARIAN CANCER (90%) − Serous carcinoma − Mucinous carcinoma − Endometroid carcinoma ◆ Category of Ovarian cancer

I.Ovarian Cancer 5 ◆ Ovarian cancer incidence and mortality Mortality 매년 200,000 명의 난소암 환자중 120,000 이 사망 대략적인 사망률 60%

I.Ovarian Cancer 6 ◆ ovarian cancer is Silent killer

I.Ovarian Cancer 7 ◆ ovarian cancer is Silent killer 전체적으로 60% 의 사망률 30 년 전이나 지금이나 의료기기의 발전에도 불구하고 사망률은 같음 25~30% 초기진단

I.Ovarian Cancer 8 ◆ Bone of ovarian cancer 여성의 호르몬 노화 방사선 생활 습관 환경적요인 유전적요인 BRCA1, BRCA2 의 돌연변이 (5~10%)

I.Ovarian Cancer II.Biomarkers 9

◆ Biomarker a substance used as an indicator of a biological state I. 실험과저 II. Biomarker * as an indicator of… Normal biological processes, Pathogenic processes, Responses to a therapy, etc. 10

I. 실험과저 II. Biomarker CA125 Mesothelin HE4 ◆ Biomarkers for ovarian cancer 11

I. 실험과저 II. Biomarker ① Monitor the response to treatment. ② Detect if cancer has come back after treatment is complete. ③ Test and monitor high-risk women who have a family history of ovarian cancer but don’t have the disease. 1. CA125 CA125 as a biomarker 12

I. 실험과저 II. Biomarker 1. CA125 It’s NOT a good screening test for ovarian cancer. Non-specificity Poor sensitivity for early-stage cancers Need for new biomarkers However, it’s not perfect. 13

I. 실험과저 II. Biomarker 2. Mesothelin 14 Limited expression in normal tissues High expression in several cancers − 40kDa protein − Differentiation antigen on normal mesothelial cells

15 Raffit Hassan, Mesothelin: A New Target for Immunotherapy, Clinical Cancer Research, Vol. 10. : pp (2004) I. 실험과저 II. Biomarker 2. Mesothelin “ Measure the level of mesothelin in the blood ”

I. 실험과저 II. Biomarker 3. HE4 16 (Human Epididymis protein 4) − 11kDa secreted protein − Precursor of the E4 (*E4 : epididymal secretory protein ) − in the blood of ovarian cancer patients, the level

I. 실험과저 II. Biomarker 3. HE4 17 (Human Epididymis protein 4) 1. Promising as a biomarker for early detection 2. Complement CA CA125 + HE4 ▶▶ Highest-level sensitivity Highest-level speciticity

I. 실험과저 II. Biomarker 18 # Diagnostic accuracy of ovarian biomarkers

Thank you 19